Afton Scientific Expands Charlottesville, Virginia, Production Center
The company will add 20 new jobs and 8,000 square feet to its facility at 2020 Avon Court to accommodate its 50 percent growth over the past year and expected similar growth in 2021.
“Afton Scientific is a 100 percent exporter of goods and services that brings dollars into Virginia,” said Afton Scientific CEO Thomas Thorpe. “Virginia offers Afton Scientific the strategic environment it needs to develop a highly trained workforce and provide well-paying pharmaceutical manufacturing jobs. It’s nice to know that some of the drugs we manufacture are targeting such diseases as Cystic Fibrosis, Breast Cancer, and Primary Immunodeficiency Disease, or utilizing the latest in mRNA therapies and monoclonal antibodies.”
The Virginia Economic Development Partnership (VEDP) worked with Albemarle County to secure the project for Virginia and will support Afton Scientific’s job creation through the Virginia Jobs Investment Program (VJIP), which provides consultative services and funding to companies creating new jobs in order to support employee recruitment and training activities. As a business incentive supporting economic development, VJIP reduces the human resource costs of new and expanding companies. VJIP is state-funded, demonstrating Virginia’s commitment to enhancing job opportunities for citizens.
“This expansion will allow Afton Scientific to grow its portfolio of important consumer healthcare products, ensuring the operation’s continued success in the Commonwealth,” said Secretary of Commerce and Trade Brian Ball. “Afton Scientific is a valued employer in a thriving industry, and we look forward to our continuing partnership with the company.”
The contract manufacturer produces small-batch sterile injectable drugs for clinical trials and commercial distribution. As a contract manufacturing organization, Afton Scientific operates Grade A/Class 100 clean rooms according to the U.S. Food and Drug Administration regulations on Good Manufacturing Practices in Charlottesville, Virginia.
“Thanks to innovative pharmaceutical companies like Afton Scientific, our Commonwealth is quickly becoming a hub for cutting-edge technology and research,” said Governor Ralph Northam. “The life sciences sector is more critical than ever as we prioritize the health of Virginians during the ongoing pandemic and work to rebuild our economy. We thank Afton Scientific for reinvesting in its operation in Albemarle County and are pleased to support the company’s next chapter of growth.”
The company also meets the regulations of Japan and the European Union. Afton Scientific’s customers include multinational pharmaceutical companies as well as emerging biotechs worldwide. Typical batch sizes are 100 to 15,000 vials, and a second facility that expects regulatory approval in early 2021 will boost the batch sizes to 40,000 vials. Afton Scientific also provides pre-sterilized and packaged components such as GMP sterile vials for customers looking to perform their own aseptic fills.
2023 Top States for Doing Business Meet the Needs of Site Selectors
The Rise of Mid-Size U.S. Cities: The Industrial Development Boom
Front Line: Brownfields Offer Redevelopment Opportunities
2023 Top States Commentary: Top-Ranked States Have What It Takes to Win Mega Projects
2023 Top States Workforce Development Programs
37th Annual Corporate Survey: Economic Pressures Exerting Greatest Effect on Decision-Makers
Immigration: A Potential Fix for Labor Shortages?
Workforce Q4 2023